You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SNDX-6352

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Metastatic Tumor, Locally Advanced Malignant Tumor Trial in United States (SNDX-6352, Durvalumab)

Completed
  • Solid Tumor
  • +3 more
  • Scottsdale, Arizona
  • +4 more
Aug 17, 2022

Unresectable Intrahepatic Cholangiocarcinoma Trial in Baltimore (Durvalumab, SNDX-6352)

Active, not recruiting
  • Unresectable Intrahepatic Cholangiocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jan 10, 2023

Chronic Graft-versus-host-disease Trial in United States (SNDX-6352)

Active, not recruiting
  • Chronic Graft-versus-host-disease
  • SNDX-6352
  • Birmingham, Alabama
  • +10 more
Aug 18, 2022

Idiopathic Pulmonary Fibrosis Trial (Axatilimab, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Nov 9, 2023

Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Feb 1, 2023

Chronic Graft-versus-host-disease Trial in Worldwide (Axatilimab)

Recruiting
  • Chronic Graft-versus-host-disease
  • Birmingham, Alabama
  • +69 more
Feb 18, 2022

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Colorectal Cancer, Solid Tumors Trial (SNDX-5613, Chemotherapy)

Not yet recruiting
  • Colorectal Cancer
  • Solid Tumors
  • (no location specified)
Feb 15, 2023

Acute Myeloid Leukemia Trial in Houston (SNDX-5613)

Recruiting
  • Acute Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Oct 3, 2022

Relapsed/Refractory Acute Leukemia Trial (SNDX-5613)

Available
  • Relapsed/Refractory Acute Leukemia
  • (no location specified)
Jun 15, 2023

Non Small Cell Lung Cancer Trial in United States (SNDX-275, erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Duarte, California
  • +11 more
Apr 25, 2022

Breast Cancer Trial in Indianapolis (SNDX-275)

Terminated
  • Breast Cancer
  • Indianapolis, Indiana
    Monet Bowling, MD
Jun 1, 2022

Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati

Recruiting
  • Relapsed/Refractory Leukemias
  • +4 more
  • Kansas City, Missouri
  • +1 more
Jul 18, 2022

Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2022

Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung Trial in United States (Entinostat, Placebo, Erlotinib)

Completed
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Carcinoma, Non-Small Cell Lung
  • Tucson, Arizona
  • +29 more
Aug 18, 2022

Hodgkin's Lymphoma Trial in United States (Entinostat)

Terminated
Has Results
  • Hodgkin's Lymphoma
  • Beverly Hills, California
  • +5 more
Oct 3, 2019

Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma Trial in United States (Azacitidine, Entinostat,

Terminated
Has Results
  • Stage IA Non-Small Cell Lung Carcinoma
  • Stage IB Non-Small Cell Lung Carcinoma
  • Los Angeles, California
  • +8 more
Jan 14, 2019

Breast Cancer Trial in Nashville (Fulvestrant, Entinostat, Placebo)

Withdrawn
  • Breast Cancer
  • Nashville, Tennessee
    Tennessee Oncololgy
Oct 6, 2014